Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 4
Submit an article Journal homepage
329
Views
5
CrossRef citations to date
0
Altmetric
Letters

Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments

Justine Seivrighta David Geffen School of Medicine, University of California, Los Angeles, CA, USAView further author information
,
Erin Colliera David Geffen School of Medicine, University of California, Los Angeles, CA, USAORCID Iconhttps://orcid.org/0000-0003-0231-9747View further author information
ORCID Icon,
Tristan Groganb Department of Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, CA, USAORCID Iconhttps://orcid.org/0000-0001-9471-2938View further author information
ORCID Icon,
Terri Shiha David Geffen School of Medicine, University of California, Los Angeles, CA, USAView further author information
,
Marcia Hogelingc Department of Medicine, Division of Dermatology, University of California Los Angeles, Los Angeles, CA, USAView further author information
,
Vivian Y. Shid Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR, USAORCID Iconhttps://orcid.org/0000-0002-7510-9428View further author information
ORCID Icon &
Jennifer L. Hsiaoc Department of Medicine, Division of Dermatology, University of California Los Angeles, Los Angeles, CA, USACorrespondence[email protected]
View further author information
 show all
Pages 2391-2393 | Received 03 May 2021, Accepted 23 May 2021, Published online: 23 Mar 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

J. L. H. is on the Board of Directors for the Hidradenitis Suppurativa Foundation and has served as an advisor for Novartis and a speaker for AbbVie. V. Y. S. is on the Board of the Directors for the Hidradenitis Suppurativa Foundation, and has served as an advisor, investigator and/or speaker for Sanofi Genzyme, Regeneron, AbbVie, Burt’s Bees, Dermira, Eli Lilly, Novartis, Pfizer, Galderma, Leo Pharma, SUN Pharma, Menlo Therapeutics, GpSkin, and Skin Actives Scientific. M. H. is an investigator for Amgen and Celgene. J. R. S., E. K. C., T. G., and T. S. report no conflicts of interest. There was no financial transaction for the preparation of this manuscript. No potential conflict of interest was reported by the author(s).

IRB approved

Reviewed and approved by UCLA IRB (#17-001267).

Additional information

Funding

Statistical analyses for this research was supported by NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant no. UL1TR001881.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.